Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.63 +0.11 (+0.37%)
As of: Sep 30, 2026 · 10:25 AM EDT

Lakefront Biotherapeutics (LKFT) Finished Goods (2020 - 2023)

Updated

Lakefront Biotherapeutics (LKFT) reported Finished Goods of $6.58 million for the quarter ended Dec 31, 2023, down 20.0% from $8.23 million a year earlier.

Analysis

Lakefront Biotherapeutics (LKFT) Finished Goods (2020 - 2023) Analysis & Trends

Dating back to the quarter ended Dec 31, 2020, Lakefront Biotherapeutics' Finished Goods record includes 4 quarters.

  • Finished Goods has a three-year compound annual growth rate of 443.0% (years ended Dec 2020 to Dec 2023).
  • By year, Finished Goods came in at $8.5 million in the year ended Dec 31, 2022 (+48.3%), $5.73 million in the year ended Dec 31, 2021 and $41,104 in the year ended Dec 31, 2020.
  • The figure for the quarter ended Dec 31, 2023 ranks as the lowest quarterly Finished Goods since the quarter ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 6.58 Mn
Dec 31, 2022 8.23 Mn
Dec 31, 2021 5.54 Mn
Dec 31, 2020 42,922.43
API Access

Lakefront Biotherapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=LKFT&period=max&api_key=YOUR_API_KEY